Australia–Israel medical ties need follow-through

On 17 June 2026, at a Melbourne reception marking Israel’s Independence Day, then Victorian premier Jacinta Allan announced plans for a long-term partnership between Victoria and leading Israeli hospitals. The announcement was an encouraging commitment to medical cooperation, but its lasting value will depend on whether researchers and clinicians develop relationships that produce meaningful scientific advances and, ultimately, better care for patients.

That ambition also gives Australia’s Jewish community a constructive role. Connections with Israel are often discussed in political and cultural terms. However, less attention is given to the professional networks linking researchers, physicians, entrepreneurs and philanthropists across the two countries. These relationships can help medical institutions move beyond introductions and identify shared challenges worth addressing together.

There are already useful examples of what such connections can achieve. In 2017, Melbourne’s Baker Heart and Diabetes Institute signed an agreement with Jerusalem’s Hadassah Medical Center to support cardiovascular and diabetes research, including researcher exchanges. In 2018, J-Wire reported that research exchanges between Baker and Israeli institutions had benefited from the support of a donor from Melbourne’s Jewish community. In 2023, Baker also hosted an innovation fellowship for Victorian medical researchers led by an Israeli life-sciences entrepreneur. Together, these initiatives show how professional ties can develop into practical research cooperation and opportunities to exchange expertise.

Building on those experiences, the next step should be to make medical research connections between Australia and Israel more systematic while keeping them focused and practical. An effective partnership begins with a scientific or medical question that both sides genuinely want to answer. In oncology, for example, one institution might have a promising experimental approach while another offers complementary clinical knowledge or research capabilities. The value lies not in placing prestigious institutional names on an agreement, but in creating a collaboration that improves what each team could accomplish independently.

Such collaboration requires more than an occasional conference, because genuine progress depends on repeated contact among scientists and clinicians, opportunities for early-career researchers to work with colleagues abroad, and institutional leaders who remain engaged after the initial announcement. A few well-chosen projects, supported over time, may achieve considerably more than an ambitious list of commitments without sustained follow-through.